Profound Medical (TSE:PRN)
TSX:PRN

Profound Medical (PRN) Ownership - Who Owns Profound Medical?

70 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Mar 28, 2024
Abbey Klair Goodman
Regional Head
xxxxxxxxxxxxx
$70099
Dec 23, 2023
Arun Menawat
Chairman & Chief Executive Officer
xxxxxxxxxxxxx
C$219174
Dec 23, 2023
Arun Menawat
Chairman & Chief Executive Officer
xxxxxxxxxxxxx
C$318026
Dec 23, 2023
Mathieu Burtnyk
Senior Officer
xxxxxxxxxxxxx
C$40988

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
13,441,792Insider55.02%186,840,909
11,828,144Insider48.42%164,411,202
11,828,144Insider48.42%164,411,202
7,400,000Insider30.29%102,860,000
564,298Institution2.31%5,713,517
462,443Insider1.89%6,427,958
279,398Institution1.14%2,828,905
145,000Institution0.59%1,468,125
95,800Institution0.39%969,975
68,000Insider0.28%945,200

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
279,398Institution1.14%2,828,905
95,800Institution0.39%969,975
14,049Institution0.06%142,246

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
15,202Institution0.06%205,987
1,673Institution<0.01%16,598
195Institution<0.01%1,948

FAQ

Who Owns Profound Medical (TSE:PRN)?
Currently, no data Available
What percentage of Profound Medical (TSE:PRN) stock is held by institutional investors?
Currently, no data Available
What percentage of Profound Medical (TSE:PRN) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Profound Medical (TSE:PRN)?
Bdc owns the most shares of Profound Medical (TSE:PRN).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis